Tharimmune, Inc. | WebDisclosure

Basculer en Français

11267	Companies
250342	Keywords
178911	Articles
136222	Press releases

Home
Companies
Tharimmune, Inc.

PRESS RELEASE

published on 05/19/2025 at 14:01, 1 year 5 months ago

Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback
Tharimmune, Inc. appoints James Gordon Liddy as strategic advisor for TH104 development, targeting high-potency opioid exposure. FDA feedback positive for prophylaxis indication

Tharimmune Inc. FDA Feedback High-Potency Opioids James Gordon Liddy TH104 Development
BRIEF

published on 05/06/2025 at 14:06, 1 year 5 months ago

Tharimmune Reports Positive Phase 1 Results for TH104

Tharimmune Inc. FDA Feedback Phase 1 Study Opioid Prophylaxis TH104 Buccal Film
BRIEF

published on 05/06/2025 at 14:06, 1 year 5 months ago

Tharimmune annonce des résultats positifs de phase 1 pour le TH104

Tharimmune Inc. Étude De Phase 1 Commentaires De La FDA Prophylaxie Aux Opioïdes Film Buccal TH104
PRESS RELEASE

published on 05/06/2025 at 14:01, 1 year 5 months ago

Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback
Tharimmune, Inc. presents promising pharmacokinetic and metabolism data of TH104, a buccal film of nalmefene, for prophylaxis against opioid exposure. Study results showcased at Digestive Disease Week 2025

Tharimmune Inc. TH104 Buccal Film Pharmacokinetic Study Opioid Prophylaxis
BRIEF

published on 05/01/2025 at 14:06, 1 year 6 months ago

Le TH104 de Tharimmune sera présenté lors de conférences médicales importantes

Biopharmaceutique TH104 Tharimmune DDW 2025 EASL 2025
BRIEF

published on 05/01/2025 at 14:06, 1 year 6 months ago

Tharimmune's TH104 to Be Presented at Notable Medical Conferences

TH104 Biopharmaceutical Tharimmune DDW 2025 EASL 2025
PRESS RELEASE

published on 05/01/2025 at 14:01, 1 year 6 months ago

Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences
Tharimmune, Inc. announces presentation of clinical data on lead drug TH104 at DDW and EASL Annual Meetings in May 2025, addressing unmet medical needs in immunology & inflammation

Tharimmune Inc. TH104 Clinical Data Immunology Unmet Medical Needs
BRIEF

published on 04/30/2025 at 14:06, 1 year 6 months ago

Tharimmune élargit son conseil d'administration avec de nouvelles nominations

Stratégie De Croissance Biopharmaceutique Direction Nominations Au Conseil D'administration Tharimmune
BRIEF

published on 04/30/2025 at 14:06, 1 year 6 months ago

Tharimmune Expands Board with New Appointments

Growth Strategy Biopharmaceutical Leadership Board Appointments Tharimmune
PRESS RELEASE

published on 04/30/2025 at 14:01, 1 year 6 months ago

Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors
Tharimmune, Inc. appoints Clay Kahler and Gary Stetz to its Board of Directors, expanding to 9 members. Kahler brings life sciences expertise while Stetz contributes financial acumen

Board Of Directors Financial Expertise Tharimmune Clay Kahler Gary Stetz

Accesswire

Published on 11/04/2026 at 00:05, 4 hours 5 minutes ago

Scoping Study Begins for High-Grade Underground Mine Feed
Published on 11/04/2026 at 00:00, 4 hours 10 minutes ago

RE Royalties Launches $5 Million Series 5 Green Bond Offering and Provides Strategic Growth Update
Published on 11/03/2026 at 23:30, 4 hours 40 minutes ago

AT&T and Amdocs Expand Collaboration, Bringing Together Amdocs aOS and AT&T's AI-Enabled Framework to Simplify Operations and Improve Customer Experiences
Published on 11/03/2026 at 23:30, 4 hours 40 minutes ago

GGL Resources Corp. Issues Post-Consolidation Shares to Strategic Metals Ltd.
Published on 11/03/2026 at 23:15, 4 hours 55 minutes ago

Petrolympic Announces Option Grant

View all ACCESSWIRE

EQS Group

Published on 11/04/2026 at 03:05, 1 hour 5 minutes ago

MEIYUME PRESENTS: BEACON AT COSMOPACK ASIA 2026
Published on 11/04/2026 at 03:05, 1 hour 5 minutes ago

How President Xi Jinping Has Charted the Course for Boosting China's Strength in Finance: Nurturing a Financial Culture with Chinese Characteristics
Published on 11/04/2026 at 02:20, 1 hour 50 minutes ago

Zhejiang and Schleswig-Holstein Mark 40 Years of Partnership with Cultural Celebration in Kiel
Published on 11/03/2026 at 22:49, 5 hours 20 minutes ago

REED annonce les montants définitifs des souscriptions aux Augmentations de Capital Réservées aux créanciers prévues par son Plan de Redressement
Published on 11/03/2026 at 22:10, 6 hours ago

BIRKENSTOCK ANNOUNCES FOURTH QUARTER AND FULL FISCAL YEAR 2026 (ENDED SEPTEMBER 30, 2026) RESULTS DATE AND CONFERENCE CALL SCHEDULED FOR DECEMBER 10, 2026

Les Echos

Published on 11/03/2026 at 18:39, 9 hours 31 minutes ago

NRJ Group - Information relative aux droits de vote au 31.10.2026 (French & English)
Published on 11/03/2026 at 18:00, 10 hours 10 minutes ago

Outstanding Shares and Voting Rights Monthly Statement - 31 October 2026
Published on 11/03/2026 at 18:00, 10 hours 10 minutes ago

Publication mensuelle du nombre d’actions composant le capital et du nombre total de droits de vote - 31 octobre 2026
Published on 11/03/2026 at 17:45, 10 hours 25 minutes ago

Declaration of voting rights at the end of October 2026
Published on 11/03/2026 at 17:45, 10 hours 25 minutes ago

Déclaration des droits de vote à fin octobre 2026

View all LES ECHOS COMFI WIRE